What this study is
The overall objective of this research is to determine whether parentese delivered in the video format (Aim 1) and in live interaction (Aim 2) facilitates novel word learning in autistic children and to investigate if there are factors that influence the effect of parentese on word learning (Aim 3).
What's being tested
- Parentese Speech
Intervention · BEHAVIORAL
Novel words are introduced in parentese, a type of speech that is typically characterized by greater pitch variation, longer duration, and louder volume
- Adult Registered Speech
Intervention · BEHAVIORAL
Novel words are introduced in standard adult register.
Study details
- Official title
- Autism Word Learning and Infant Directed-Speech
- Sponsor
- The University of Texas at Dallas
- Conditions
- Autism · Autism Spectrum Disorder · Neurodevelopmental Disorders
- Enrolling
- 100 people
- Starts
- 2024-10-04
- Est. completion
- 2028-03-01
- Design
- Single-blind, non-randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Months – 59 MonthsSex ALLHealthy volunteers AcceptedYou may qualify if
- Children with or without a diagnosis of ASD between 18 and 59 months
You can't join if
- Hears another language more than 10% of time based on parent report
- Has uncorrected visual impairment or hearing impairment
- Has developmental disorders or medical conditions other than ASD that affect language or cognition (excepting psychiatric conditions often comorbid with ASD such as ADHD)
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openUniversity of Texas at Dallas
Richardson, Texas, United States
- Pumpki L. Su, PhD · Contact973-883-2384lei.su@utdallas.edu
- McKenzie Cullinan, MS · Contactmckenzie.cullinan@utdallas.edu
- Pumpki L. Su, PhD · Principal investigator
Recruiting
Study team
Sponsor
The University of Texas at Dallas
Study ID IRB-24-616
Principal investigator
Pumpki L. Su, PhD
The University of Texas at Dallas
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.